Skip to main content

Exchange Traded Concepts, LLC

SEC CIK
0001457320
Latest filing
Aug 11, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
15,357
Value
$7.63M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Exchange Traded Concepts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,357$7.63M<0.1%+1,482+10.7%AddedHolders
Q1 202613,875$6.20M<0.1%+1,850+15.4%AddedHolders
Q4 202512,025$5.45M<0.1%+1,874+18.5%AddedHolders
Q3 202510,151$3.98M<0.1%+7,565+292.5%AddedHolders
Q2 20252,586$1.15M<0.1%−37−1.4%ReducedHolders
Q1 20252,623$1.27M<0.1%−322−10.9%ReducedHolders
Q4 20242,945$1.19M<0.1%−13−0.4%ReducedHolders
Q3 20242,958$1.38M<0.1%−2,355−44.3%ReducedHolders
Q2 20245,313$2.49M0.1%−128−2.4%ReducedHolders
Q1 20245,441$2.27M0.1%−2,318−29.9%ReducedHolders
Q4 20237,759$3.16M0.1%−1,371−15.0%ReducedHolders
Q3 20239,130$3.17M0.1%+799+9.6%AddedHolders
Q2 20238,331$2.93M0.1%−1,926−18.8%ReducedHolders
Q1 202310,257$3.23M0.1%+1,761+20.7%AddedHolders
Q4 20228,496$2.45M0.1%−2,390−22.0%ReducedHolders
Q3 202210,886$3.15M0.1%−867−7.4%ReducedHolders
Q2 202211,753$3.31M0.1%−2,299−16.4%ReducedHolders
Q1 202214,052$3.67M0.1%+1,942+16.0%AddedHolders
Q4 202112,110$2.66M0.1%−3,346−21.6%ReducedHolders
Q3 202115,456$2.80M0.1%−11,217−42.1%ReducedHolders
Q2 202126,673$5.38M0.2%+15,666+142.3%AddedHolders
Q1 202111,007$2.37M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.